SANOFICONR4,180.00

Sanofi Consumer Healthcare India Limited

· Pharma & Health
₹ CrorePeersPGHLSANOFISENORESINNOVACAPMOREPENLABIOLCPFDCASTRAZENMcap ₹9,614 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY25
31/12/2024
FY26
31/12/2025
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation4.511.7
+ Impairment Loss / (Reversal)2.90.0
+ Finance Costs3.92.0
+ Interest Income-11.8-15.2
+ Share-based Payments1.0-1.0
+ Unrealised FX (Gain) / Loss-0.1-2.8
+ Other Non-cash Items0.10.0
Changes in Working Capital
+ Inventories55.7-21.0
+ Trade Receivables — Current17.9-14.0
+ Other Financial Assets — Current200.94.3
+ Other Financial Assets — Non-current-2.80.4
+ Other Current Assets-5.7-21.7
+ Other Bank Balances0.0-0.4
+ Trade Payables — Current10.39.3
+ Other Financial Liabilities — Current0.02.3
+ Other Current Liabilities27.0-13.0
+ Provisions — Current12.81.0
Cash from Operating Activities
Profit Before Tax (per I/S)246.8320.3357.2
+ Total Adjustments (incl. Working Capital)316.6-58.1
Cash from Operations (pre-tax)563.4262.2
+ Interest Received — Operating0.015.2
+ Income Taxes Paid124.40.0
Cash from Operating Activities439.0277.4
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)9.97.6
+ Interest Received — Investing11.80.0
Cash from Investing Activities1.9-7.6
Cash from Financing Activities
+ Payment of Lease Liabilities0.07.8
+ Payment of Finance Lease Liabilities0.4
+ Interest Paid115.20.0
+ Dividends Paid0.0126.7
+ Income Taxes (Paid) / Refund — Financing0.087.4
Cash from Financing Activities-115.6-221.9
Net Changes in Cash (pre-FX)325.347.9
Net Changes in Cash325.347.9
Closing Cash326.9
Reference Items
EBITDA270.6309.0352.9
EBITDA Margin %37.3535.1837.16
Free Cash Flow (CFO − Capex)429.1269.8269.8
Free Cash Flow to Equity269.8
Free Cash Flow per Basic Share186.57117.30117.30
Price to Free Cash Flow35.63
Cash Flow to Net Income2.431.16
Cash Paid for Taxes124.40.0
Cash Paid for Interest115.20.0
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.